Search
Close this search box.

Month: September 2024

Youth Minister attends YLP10 closing ceremony

Manama, Rawan bint Najeeb Tawfiqi, Minister of Youth Affairs, attended the closing ceremony of the 10th edition of the Young Leaders Programme (YLP10), organised in partnership with the United Nations Development Programme (UNDP) in Bahrain.

Jihan A…

Bahrain All Share Index marks 1,944.41 points

Manama, Bahrain All Share Index has closed at 1,944.41 points, marking a decrease of 3.82 points below the previous closing.

This decrease was due to the drop in the communications services sector and materials sector.

Bahrain Islamic Index has clo…

Music Licensing, Inc. (OTC: SONG) Announces Acquisition of Royalty Rights to “Thank God I Got It” by Desiigner, Bolstering Its Diverse and Star-Studded Portfolio

NAPLES, Fla., Sept. 03, 2024 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG), a leading entity in the music industry, is excited to announce the acquisition of the royalty rights to “Thank God I Got It” by the renowned artist Desiigner. This acquisition underscores Music Licensing, Inc.’s commitment to diversifying its portfolio with high-quality, revenue-generating […]

‫شركة Music Licensing, Inc. (OTC: SONG) تعلن استحواذها على حقوق ملكية أغنية “Thank God I Got It” للفنان Desiigner، مما يعزز محفظتها المتنوعة والزاخرة بالنجوم

نيبلز، فلوريدا،, Sept. 03, 2024 (GLOBE NEWSWIRE) — يَسُر شركة Music Licensing, Inc. (OTC: SONG)، وهي كيان رائد في صناعة الموسيقى، أن تعلن عن استحواذها على حقوق ملكية أغنية “Thank God I Got It” للفنان الشهير Desiigner. ويؤكد هذا الاستحواذ على التزام شركة Music Licensing, Inc. بتنويع محفظتها بأصول عالية الجودة ومُدرّة للإيرادات. تُضَاف عملية […]

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies. SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to […]